menitorix

Vaccineexperimental

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • menitorix

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02002156Phase 4Jun 1, 2014University of Oxford
NCT01896596Phase 4Jul 1, 2013Department of Health, United Kingdom, Public Health England, University of London
NCT01553279Phase 3Mar 1, 2012Sanofi-Aventis
NCT00871338Phase 2Jun 1, 2009GlaxoSmithKline
NCT00891176Phase 3May 1, 2009GlaxoSmithKline
NCT00586612Phase 3Dec 1, 2007GlaxoSmithKline
NCT00503165Phase 4Jul 1, 2007Public Health England
NCT00454987Phase 4May 1, 2007GlaxoSmithKline
NCT00463437Phase 3Apr 1, 2007GlaxoSmithKline
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GlaxoSmithKlineFor profit5532007
Public Health EnglandGovernment2212007
Department of Health, United KingdomGovernment1012013
Sanofi-AventisFor profit1112012
University of LondonAcademic/Hospital1012013
University of OxfordAcademic/Hospital1112014
6 organizations
Page 1 / 1